Blueprint Medicines Corp (BPMC):企業のM&A・提携動向(医療機器分野)

【英語タイトル】Blueprint Medicines Corp (BPMC) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(GDME325832D)・商品コード:GDME325832D
・発行会社(調査会社):GlobalData
・発行日:2017年2月14日
・ページ数:30
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Blueprint Medicines Corp (Blueprint) is a biotechnology company that develops drugs for the treatment of cancers. The company discovers selective kinase inhibitors for genomically defined cancer subsets. It has developed a platform which combines kinase inhibitors with genomics, and develops selective compounds against clear genomic driver targets. Blueprint identifies drug targets by sequencing cancers and mining public data with new genome analysis algorithms. The company’s programs comprise KIT D816V selective inhibitor, FGFR4 selective inhibitor, and other programs. It also operates through genomic and cancer research institutions located in the US. Blueprint is headquartered in Cambridge, Massachusetts, the US.

Blueprint Medicines Corp (BPMC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Blueprint Medicines Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Blueprint Medicines Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Blueprint Medicines Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Blueprint Medicines Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Blueprint Medicines Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Blueprint Medicines Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Blueprint Medicines Raises US$25 Million In Series B Venture Financing 10
Blueprint Medicines Raises US$40 Million In Series A Venture Financing 11
Partnerships 12
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems 12
Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 13
Blueprint Medicines Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Massachusetts General Hospital Cancer Center 14
Equity Offering 15
Blueprint Medicines Raises USD143.8 Million in Public Offering of Shares 15
Blueprint Medicines Corp – Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Nov 10, 2016: Blueprint Medicines Reports Third Quarter 2016 Financial Results 20
Aug 09, 2016: Blueprint Medicines Reports Second Quarter 2016 Financial Results 22
May 10, 2016: Blueprint Medicines Reports First Quarter 2016 Financial Results 23
Mar 11, 2016: Blueprint Medicines Reports Fourth Quarter and Full Year 2015 Financial Results 25
Corporate Communications 27
Nov 14, 2016: Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a Newly Created Executive Vice President Role 27
Sep 06, 2016: Blueprint Medicines Announces Appointment of Tracey McCain as Chief Legal Officer and Executive Vice President 28
Apr 15, 2016: Blueprint Medicines Appoints Lynn Seely, M.D. to Board of Directors 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Blueprint Medicines Corp, Medical Equipment, Key Facts, 2015 1
Blueprint Medicines Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Blueprint Medicines Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Blueprint Medicines Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Blueprint Medicines Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Blueprint Medicines Corp, Deals By Market, 2011 to YTD 2017 8
Blueprint Medicines Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Blueprint Medicines Raises US$25 Million In Series B Venture Financing 10
Blueprint Medicines Raises US$40 Million In Series A Venture Financing 11
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems 12
Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 13
Blueprint Medicines Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Massachusetts General Hospital Cancer Center 14
Blueprint Medicines Raises USD143.8 Million in Public Offering of Shares 15
Blueprint Medicines Corp, Key Competitors 17
Blueprint Medicines Corp, Key Employees 18
Blueprint Medicines Corp, Subsidiaries 19

List of Figures
Blueprint Medicines Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Blueprint Medicines Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Blueprint Medicines Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Blueprint Medicines Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Blueprint Medicines Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Blueprint Medicines Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Blueprint Medicines Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Blueprint Medicines Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

★調査レポート[Blueprint Medicines Corp (BPMC):企業のM&A・提携動向(医療機器分野)] (コード:GDME325832D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Blueprint Medicines Corp (BPMC):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆